Stock FAQs

insy stock price

by Berry Schuster Published 3 years ago Updated 2 years ago
image

0.0420

What are analysts'target prices for Insys Therapeutics'stock?

4 Wall Street analysts have issued 12 month target prices for Insys Therapeutics' shares. Their forecasts range from $4.00 to $11.00. On average, they expect Insys Therapeutics' stock price to reach $6.60 in the next year. View Analyst Price Targets for Insys Therapeutics.

What is the ticker symbol for Insys Therapeutics?

INSYS Therapeutics trades on the NASDAQ under the ticker symbol "INSY." How much money does INSYS Therapeutics make? INSYS Therapeutics has a market capitalization of $0.00 and generates $82.08 million in revenue each year.

When did Insys Therapeutics stock split in 2014?

INSYS Therapeutics's stock split on the morning of Monday, March 31st 2014. The 3-2 split was announced on Tuesday, March 4th 2014. The newly minted shares were payable to shareholders after the market closes on Friday, March 28th 2014.

What is Insys Therapeutics's return on equity?

INSYS Therapeutics had a negative trailing twelve-month return on equity of 1,430.37% and a negative net margin of 346.61%. INSYS Therapeutics's revenue was down 68.1% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.19) earnings per share. View INSYS Therapeutics' earnings history.

image

How were INSYS Therapeutics' earnings last quarter?

INSYS Therapeutics, Inc. (NASDAQ:INSY) issued its quarterly earnings results on Friday, May, 10th. The specialty pharmaceutical company reported ($...

When did INSYS Therapeutics' stock split? How did INSYS Therapeutics' stock split work?

Shares of INSYS Therapeutics split on Monday, March 31st 2014. The 3-2 split was announced on Tuesday, March 4th 2014. The newly issued shares were...

Who are INSYS Therapeutics' key executives?

INSYS Therapeutics' management team includes the following people: Mr. Steven J. Meyer , Exec. Chairman (Age 62) Mr. Saeed Motahari , CEO, Pres...

Who are some of INSYS Therapeutics' key competitors?

Some companies that are related to INSYS Therapeutics include Capricor Therapeutics (CAPR) , Xilio Therapeutics (XLO) , TherapeuticsMD (TXMD) ,...

What other stocks do shareholders of INSYS Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other INSYS Therapeutics investors own include Cara Therapeutics...

What is INSYS Therapeutics' stock symbol?

INSYS Therapeutics trades on the NASDAQ under the ticker symbol "INSY."

How much money does INSYS Therapeutics make?

INSYS Therapeutics (NASDAQ:INSY) has a market capitalization of $0.00 and generates $82.08 million in revenue each year. The specialty pharmaceutic...

How many employees does INSYS Therapeutics have?

INSYS Therapeutics employs 226 workers across the globe.

What is INSYS Therapeutics' official website?

The official website for INSYS Therapeutics is www.insysrx.com .

Component Grades

Insys Therapeutics, Inc. (INSY) Company Bio

We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9